Kaiser Permanente Colorado
Welcome,         Profile    Billing    Logout  
 19 Trials 
38 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Glanz, Jason M
NCT03241771: Impact of Direct Outreach to Expand Access to Naloxone in the Context of Standing Orders

Completed
N/A
325
US
Naloxone Navigator 1.0, Naloxone Navigator (NN)
Kaiser Permanente, Denver Health and Hospital Authority, National Institute on Drug Abuse (NIDA)
Opioid Abuse, Overdose, Risk Behavior
08/18
08/22
NCT03337009: The Impact of a Web-Based Naloxone Intervention Under Standing Orders to Patients Prescribed Chronic Opioid Therapy

Active, not recruiting
N/A
1004
US
Naloxone Navigator (NN)
Kaiser Permanente, National Institute on Drug Abuse (NIDA)
Overdose, Risk Behavior
04/20
06/24
NCT03337100: The Impact of Co-Dispensing Naloxone to Patients Prescribed Chronic Opioid Therapy

Completed
N/A
7
US
Co-Dispensing
Kaiser Permanente, Denver Health and Hospital Authority, National Institute on Drug Abuse (NIDA)
Overdose, Risk Behavior
04/21
09/22
NCT05944133: Health Insurance Instability and Mortality Among Patients Receiving Bup Tx for OUD

Active, not recruiting
N/A
27257
US
No intervention, observational retrospective study
Kaiser Permanente, National Institute on Drug Abuse (NIDA)
Opioid Use Disorder, Opioid Overdose, Death
02/25
02/26
Nguyen, Anh
NCT04897269: Progesterone Supplementation on Women Having Low Progesterone Levels on Transfer Day

Recruiting
3
824
RoW
Progesterone supplementation
Tu Du Hospital
Assisted Reproductive Technology
05/24
06/24
GuidePath, NCT04838613 / 2020-003959-16: Study of Diagnostic Performance of [18F]CTT1057 in BCR

Completed
3
180
Europe, US
[18F]CTT1057, [68Ga]Ga-PSMA-11
Novartis Pharmaceuticals, Novartis Pharma AG
Prostatic Neoplasms, Prostate Cancer, Recurrence
11/23
11/23
NCT04433104: Umbilical Cord Mesenchymal Stem Cells Transplantation in the Treatment of Chronic Obstructive Pulmonary Disease

Completed
1/2
40
RoW
Umbilical Cord Mesenchymal Stem Cells transplantation, drug therapy according to Vietnamese MOHS procedure
Vinmec Research Institute of Stem Cell and Gene Technology
COPD
07/21
12/22
NCT06588348: Corticosteroid Effect on Achalasia Variant EGJOO

Recruiting
1
10
US
Steroid treatment, Prednisone, Esophageal Manometry, Survey, Eckardt and Brief Esophageal Dysphagia Questionnaire (BEDQ)
Baylor Research Institute
Esophagogastric Junction Outflow Obstruction
12/24
12/24
NCT04531644: Double Stimulation in Women With Low Prognosis in ART

Recruiting
N/A
100
RoW
double stimulation, DuoStim, conventional ovarian stimulation
Tu Du Hospital, Federico II University, University of Medicine and Pharmacy at Ho Chi Minh City
Assisted Reproductive Techniques
02/24
03/24
NCT05783856: Effects of LiveSpo X-secret in Supporting Treatment of Sexually Transmitted Diseases

Completed
N/A
100
RoW
LiveSpo X-secret, Registration number: No.220003286/PCBA-HN, 0.9% NaCl physiological saline, Registration number: VD-32723-19
Anabio R&D, Hanoi University of Science
Sexually Transmitted Diseases
03/23
03/23
DR-AHF, NCT04331132: Tolvaptan add-on Therapy to Overcome Loop Diuretic Resistance in Acute Heart Failure With Renal Dysfunction

Recruiting
N/A
128
RoW
Tolvaptan 15 MG, Samsca
Gia Dinh People Hospital, Otsuka Pharmaceutical Vietnam
Acute Heart Failure
06/23
07/23
NCT06406582: Treatment Result of Zirconia Laminate Veneer

Recruiting
N/A
50
RoW
Zirconia laminate veneer, Lithium Disilicate laminate veneer
Hanoi Medical University
Dislocation, Tooth, Teeth, Endodontically-Treated, Tooth Fracture, Tooth Injuries, Tooth Abnormalities, Cracked Tooth Syndrome, Tooth Crowding
12/25
12/25
NCT06165354: Effects of LiveSpo X-SECRET in SupportiveTreatment of Vaginitis

Recruiting
N/A
120
RoW
0.9% NaCl physiological saline, Registration number: VD-32723-19, LiveSpo X-secret, Registration number: No.220003286/PCBA-HN, Registration number: 14981/22/CBMP-HA
Anabio R&D, Hanoi Obstetrics and Gynecology Hospital, Centers for Disease Control and Prevention
Vaginitis
12/24
12/24
NCT06148194: Efficacy of Probiotics (LiveSpo Navax) in Preventing Respiratory Diseases in Children

Recruiting
N/A
600
RoW
0.9% NaCl physiological saline, Registration number: VD-32723-19, Probiotic 1, Registration number: No.210001337/PCBA-HN, Probiotic 2, Registration number: No. 220002534/PCBA-HN
Anabio R&D, Hanoi Medical University
Respiratory Disease, Respiratory Infections in Children
09/24
12/24
NCT04948450: A Multidomain Intervention Program for Older People With Dementia

Completed
N/A
60
RoW
Physical activity intervention, Cognitive stimulation intervention, Social intervention, Management of metabolic and vascular risk factors
National Geriatric Hospital
Dementia, Alzheimer Disease, Dementia, Mixed
01/24
01/24
NCT05929599: Efficacy of LiveSpo Navax in Supportive Treatment of Pneumonia in Children With RSV and Bacterial Co-infections

Active, not recruiting
N/A
120
RoW
0.9% NaCl physiological saline, Registration number: VD-32723-19, LiveSpo Navax, Registration number: No.210001337/PCBA-HN
National Children's Hospital, Vietnam, Anabio R&D
Acute Respiratory Tract Infections, Pneumonia, Respiratory Syncytial Virus (RSV)
05/24
10/24
NCT06599710: The Effects of a Food Product Containing Mushroom Extracts (AndoSanTM) in Subjects with Colorectal Cancer-related Fatigue

Recruiting
N/A
30
Europe
AndoSanTM
Mycotech Pharma AS, BioTeSys GmbH
Cancer-related Fatigue
02/25
02/25
NCT06606444: Feasibility Study of Placement and Surfactant Administration Through a Preterm Size Laryngeal Mask Airway in Very Low Birth Weight Neonates with Respiratory Distress Syndrome

Recruiting
N/A
25
RoW
Surfactant Administration Through Laryngeal or Supraglottic Airways, Laryngeal mask airway surfactant administration, Surfactant Therapy via Laryngeal Mask Airway, Laryngeal Mask Airway for Surfactant Administration in Neonates, Supraglottic airway devices for surfactant treatment
Karolinska Institutet, Hanoi Medical University, Hanoi Obstetrics and Gynecology Hospital, The Sahlgrenska Academy at University of Gothenburg
Respiratory Distress Syndrome, Newborn
11/24
12/25
NCT05944133: Health Insurance Instability and Mortality Among Patients Receiving Bup Tx for OUD

Active, not recruiting
N/A
27257
US
No intervention, observational retrospective study
Kaiser Permanente, National Institute on Drug Abuse (NIDA)
Opioid Use Disorder, Opioid Overdose, Death
02/25
02/26
NICEST, NCT05312775: Niche In CEsarean Scar Trial

Recruiting
N/A
938
RoW
Double-layer uterine closure, Single-layer uterine closure
Nguyen Thi Thu Ha
Niche
04/26
10/26
Beck, Arne
NCT06556589: Collaborative Care for Treatment of Depression and Anxiety

Recruiting
N/A
200
US
Collaborative Care
Kaiser Permanente, Garfield Memorial Fund
Depression, Anxiety
09/24
03/25
GGC4H, NCT04040153: Guiding Good Choices for Health

Active, not recruiting
N/A
3636
US
Guiding Good Choices, Preparing for the Drug-Free Years
University of Washington, Kaiser Permanente, Henry Ford Health System, National Center for Complementary and Integrative Health (NCCIH)
Adolescent Substance Use
05/25
05/25
MMB4Moms, NCT04846504: Accelerating Implementation of Mindful Mood Balance for Moms

Completed
N/A
423
US
MMBFM program with clinician coach support, MMBFM program with peer coach support, Patient facing strategy intervention arm, Patient facing plus clinic facing strategy intervention arm
Kaiser Permanente, HealthPartners Institute, Georgia State University, University of Colorado, Boulder, University of Toronto, Emory University, National Institute of Mental Health (NIMH)
Perinatal Depression
06/23
08/23
Wang, Xiaoming
NCT05253053: To Evaluate Efficacy and Safety of TT-00420 (Tinengotinib) as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors

Recruiting
1/2
114
RoW
TT-00420, Combination Product: Atezolizumab, Combination Product: Nab-Paclitaxel
TransThera Sciences (Nanjing), Inc.
Advanced Solid Tumor, Cholangiocarcinoma, Biliary Tract Cancer, HER2-negative Breast Cancer, Triple Negative Breast Cancer, Small-cell Lung Cancer, Bladder Cancer, Prostate Cancer, Thyroid Cancer, Gastric Cancer, Gallbladder Cancer
09/24
12/24
NCT05103748: Function Evaluation of Older Patients With Vertigo and Intervention Study of New Rehabilitation Methods

Recruiting
N/A
226
RoW
Traditional vestibular rehabilitation, Cognitive and vestibular dual task training
Xijing Hospital
Vertigo
08/22
12/23
NCT06218043: An Iodine Balance Study to Investigate the Recommended Iodine Intake in an Elderly Population

Recruiting
N/A
30
RoW
Restrict subjects' intake of iodine-containing foods
Wenxing Guo, Tianjin Medical University General Hospital, Gansu Provincial Centre for Disease Control and Prevention
Nutrition, Healthy
06/25
12/25
NCT05944133: Health Insurance Instability and Mortality Among Patients Receiving Bup Tx for OUD

Active, not recruiting
N/A
27257
US
No intervention, observational retrospective study
Kaiser Permanente, National Institute on Drug Abuse (NIDA)
Opioid Use Disorder, Opioid Overdose, Death
02/25
02/26
NCT05716191: Study on the Relationship Between Iodine Nutrition and Thyroid Diseases in the Elderly

Recruiting
N/A
1000
RoW
Naturally different iodine levels exposure
Tianjin Medical University, Tianjin Medical University General Hospital, Shandong Provincial Institute for Endemic Disease Control
Nutrition, Healthy, Elderly
06/25
12/25
Binswanger, Ingrid
NCT06323824: Office-based Methadone Versus Buprenorphine to Address Retention in Medication for Opioid Use Disorder Treatment.

Recruiting
4
600
US
Methadone, Buprenorphine (BUP)
Yale University, National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA), The Emmes Company, LLC, University of California, San Francisco, Boston Medical Center (BMC), Hennepin Healthcare Research Institute, Alameda Health System, Marshall Health, Kaiser Permanente
Opioid Use Disorder
12/28
05/29
NCT03241771: Impact of Direct Outreach to Expand Access to Naloxone in the Context of Standing Orders

Completed
N/A
325
US
Naloxone Navigator 1.0, Naloxone Navigator (NN)
Kaiser Permanente, Denver Health and Hospital Authority, National Institute on Drug Abuse (NIDA)
Opioid Abuse, Overdose, Risk Behavior
08/18
08/22
NCT03337009: The Impact of a Web-Based Naloxone Intervention Under Standing Orders to Patients Prescribed Chronic Opioid Therapy

Active, not recruiting
N/A
1004
US
Naloxone Navigator (NN)
Kaiser Permanente, National Institute on Drug Abuse (NIDA)
Overdose, Risk Behavior
04/20
06/24
NCT03337100: The Impact of Co-Dispensing Naloxone to Patients Prescribed Chronic Opioid Therapy

Completed
N/A
7
US
Co-Dispensing
Kaiser Permanente, Denver Health and Hospital Authority, National Institute on Drug Abuse (NIDA)
Overdose, Risk Behavior
04/21
09/22
NCT05365750: COVID-19 Antibody and Reinfection Study

Active, not recruiting
N/A
4235
US
Kaiser Permanente
COVID-19 Testing
03/23
12/24
NCT05944133: Health Insurance Instability and Mortality Among Patients Receiving Bup Tx for OUD

Active, not recruiting
N/A
27257
US
No intervention, observational retrospective study
Kaiser Permanente, National Institute on Drug Abuse (NIDA)
Opioid Use Disorder, Opioid Overdose, Death
02/25
02/26
SCHARP, NCT05989282: Structural Conditions and Health After Release From Prison

Recruiting
N/A
400
US
Kaiser Permanente, University of Colorado, Denver, Denver Health and Hospital Authority, National Heart, Lung, and Blood Institute (NHLBI)
Cardiovascular Diseases, Health Care Utilization
06/27
06/28
Ha, Duc M
NCT05059132: Inspiratory Muscle Training and Behavioral Support to Alleviate Dyspnea and Promote Walking in Lung Cancer Survivors: A Pilot Study

Completed
N/A
31
US
Tele-rehabilitation, Education only
Kaiser Permanente, American Lung Association
Lung Neoplasm
12/22
12/22
NCT06016348: PROMISE: PRedictors Of Good outcoMes in Thrombectomy for Large Infarct Core Stroke Evaluation

Recruiting
N/A
160
RoW
Endovascular treatment, Mechanical thrombectomy
115 People's Hospital, University of Medicine and Pharmacy at Ho Chi Minh City
Acute Ischemic Stroke
09/25
12/25
NCT05179408: Multi-Targeted Telerehabilitation Following Curative Intent Therapy of Lung Cancer

Not yet recruiting
N/A
40
US
Targeted-telerehabilitation, Waitlist
VA Office of Research and Development
Lung Cancer, Cancer Survivors
03/26
12/26

Download Options